Loading…
Enhancing the diagnostic capacity of 18FPSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study
To investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [18F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in patients with primary prostate cancer (PC).BACKGR...
Saved in:
Published in: | EJNMMI reports 2024-11, Vol.8 (1), p.37 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 1 |
container_start_page | 37 |
container_title | EJNMMI reports |
container_volume | 8 |
creator | Glemser, Philip Alexander Freitag, Martin Kovacs, Balint Netzer, Nils Dimitrakopoulou-Strauss, Antonia Haberkorn, Uwe Maier-Hein, Klaus Schwab, Constantin Duensing, Stefan Beuthien-Baumann, Bettina Schlemmer, Heinz-Peter Bonekamp, David Giesel, Frederik Sachpekidis, Christos |
description | To investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [18F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in patients with primary prostate cancer (PC).BACKGROUNDTo investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [18F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in patients with primary prostate cancer (PC).A total of seven patients underwent whole-body [18F]-PSMA-1007 PET/MRI examinations including a pelvic mpMRI protocol with T2w, diffusion weighted imaging (DWI) and DCE image series. Conventional analysis included visual reading of PET/MRI images and Prostate Imaging Reporting & Data System (PI-RADS) scoring of the prostate. On the prostate level, we performed manual segmentations for time-intensity curve parameter formation and semi-quantitative analysis based on DCE segmentation data of PC-suspicious lesions. Moreover, we applied a recently introduced deep learning (DL) pipeline previously trained on 1010 independent MRI examinations with systematic biopsy-enhanced histopathological targeted biopsy lesion ground truth in order to perform AI-based lesion detection, prostate segmentation and derivation of a deep learning PI-RADS score. DICE coefficients between manual and automatic DL-acquired segmentations were compared. On patient-based analysis, PET/MRI revealed PC-suspicious lesions in the prostate gland in 6/7 patients (Gleason Score-GS ≥ 7b) that were histologically confirmed. Four of these patients also showed lymph node metastases, while two of them had bone metastases. One patient with GS 6 showed no PC-suspicious lesions. Based on DCE segmentations, a distinction between PC-suspicious and normal appearing tissue was feasible with the parameters fitted maximum contrast ratio (FMCR) and wash-in-slope. DICE coefficients (manual vs. deep learning) were comparable with literature values at a mean of 0.44. Further, the DL pipeline could identify the intraprostatic PC-suspicious lesions in all six patients with clinically significant PC.RESULTSA total of seven patients underwent whole-body [18F]-PSMA-1007 PET/MRI examinations including a pelvic mpMRI protocol with T2w, diffusion weighted imaging (DWI) and DCE image series. Conventional analysis included visual readin |
doi_str_mv | 10.1186/s41824-024-00225-5 |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_3128320894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3128320894</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_31283208943</originalsourceid><addsrcrecordid>eNqVjTFPwzAQhS0EEhX0DzDdyBJ6jpMmsKGSqgyVKujAVp1cJzmUOGnsAP1J_EtciYGV4fTu6d73TogbiXdS5vOZS2QeJxGeBuM4jdIzMVGIaYRZ8nb-Z78UU-feEVEpzGI1n4jvwtZkNdsKfG1gz1TZznnWoKknzf4IXQkyX25e14-RRMxgU2xn65dnYAv9wC0Nx6CBIW8CZLUZIJjqVPnJvgYaPJesmZqAeNM0XJmQArJ7cKbl6DCS9Rx4_jDwtCgewgnMV990A_ku1Ds_7o_X4qKkxpnpr16J22WxXayi8PwwGud3LTsd6smabnQ7JeNcxZjfJ-of0R81-Wno</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128320894</pqid></control><display><type>article</type><title>Enhancing the diagnostic capacity of 18FPSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study</title><source>Springer Nature - SpringerLink Journals - Fully Open Access </source><source>PubMed Central</source><creator>Glemser, Philip Alexander ; Freitag, Martin ; Kovacs, Balint ; Netzer, Nils ; Dimitrakopoulou-Strauss, Antonia ; Haberkorn, Uwe ; Maier-Hein, Klaus ; Schwab, Constantin ; Duensing, Stefan ; Beuthien-Baumann, Bettina ; Schlemmer, Heinz-Peter ; Bonekamp, David ; Giesel, Frederik ; Sachpekidis, Christos</creator><creatorcontrib>Glemser, Philip Alexander ; Freitag, Martin ; Kovacs, Balint ; Netzer, Nils ; Dimitrakopoulou-Strauss, Antonia ; Haberkorn, Uwe ; Maier-Hein, Klaus ; Schwab, Constantin ; Duensing, Stefan ; Beuthien-Baumann, Bettina ; Schlemmer, Heinz-Peter ; Bonekamp, David ; Giesel, Frederik ; Sachpekidis, Christos</creatorcontrib><description>To investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [18F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in patients with primary prostate cancer (PC).BACKGROUNDTo investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [18F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in patients with primary prostate cancer (PC).A total of seven patients underwent whole-body [18F]-PSMA-1007 PET/MRI examinations including a pelvic mpMRI protocol with T2w, diffusion weighted imaging (DWI) and DCE image series. Conventional analysis included visual reading of PET/MRI images and Prostate Imaging Reporting & Data System (PI-RADS) scoring of the prostate. On the prostate level, we performed manual segmentations for time-intensity curve parameter formation and semi-quantitative analysis based on DCE segmentation data of PC-suspicious lesions. Moreover, we applied a recently introduced deep learning (DL) pipeline previously trained on 1010 independent MRI examinations with systematic biopsy-enhanced histopathological targeted biopsy lesion ground truth in order to perform AI-based lesion detection, prostate segmentation and derivation of a deep learning PI-RADS score. DICE coefficients between manual and automatic DL-acquired segmentations were compared. On patient-based analysis, PET/MRI revealed PC-suspicious lesions in the prostate gland in 6/7 patients (Gleason Score-GS ≥ 7b) that were histologically confirmed. Four of these patients also showed lymph node metastases, while two of them had bone metastases. One patient with GS 6 showed no PC-suspicious lesions. Based on DCE segmentations, a distinction between PC-suspicious and normal appearing tissue was feasible with the parameters fitted maximum contrast ratio (FMCR) and wash-in-slope. DICE coefficients (manual vs. deep learning) were comparable with literature values at a mean of 0.44. Further, the DL pipeline could identify the intraprostatic PC-suspicious lesions in all six patients with clinically significant PC.RESULTSA total of seven patients underwent whole-body [18F]-PSMA-1007 PET/MRI examinations including a pelvic mpMRI protocol with T2w, diffusion weighted imaging (DWI) and DCE image series. Conventional analysis included visual reading of PET/MRI images and Prostate Imaging Reporting & Data System (PI-RADS) scoring of the prostate. On the prostate level, we performed manual segmentations for time-intensity curve parameter formation and semi-quantitative analysis based on DCE segmentation data of PC-suspicious lesions. Moreover, we applied a recently introduced deep learning (DL) pipeline previously trained on 1010 independent MRI examinations with systematic biopsy-enhanced histopathological targeted biopsy lesion ground truth in order to perform AI-based lesion detection, prostate segmentation and derivation of a deep learning PI-RADS score. DICE coefficients between manual and automatic DL-acquired segmentations were compared. On patient-based analysis, PET/MRI revealed PC-suspicious lesions in the prostate gland in 6/7 patients (Gleason Score-GS ≥ 7b) that were histologically confirmed. Four of these patients also showed lymph node metastases, while two of them had bone metastases. One patient with GS 6 showed no PC-suspicious lesions. Based on DCE segmentations, a distinction between PC-suspicious and normal appearing tissue was feasible with the parameters fitted maximum contrast ratio (FMCR) and wash-in-slope. DICE coefficients (manual vs. deep learning) were comparable with literature values at a mean of 0.44. Further, the DL pipeline could identify the intraprostatic PC-suspicious lesions in all six patients with clinically significant PC.Firstly, semi-quantitative DCE analysis based on manual segmentations of time-intensity curves was able to distinguish benign from malignant tissues. Moreover, DL analysis of the MRI data could detect clinically significant PC in all cases, demonstrating the feasibility of AI-supported approaches in increasing diagnostic certainty of PSMA-radioligand PET/MRI.CONCLUSIONFirstly, semi-quantitative DCE analysis based on manual segmentations of time-intensity curves was able to distinguish benign from malignant tissues. Moreover, DL analysis of the MRI data could detect clinically significant PC in all cases, demonstrating the feasibility of AI-supported approaches in increasing diagnostic certainty of PSMA-radioligand PET/MRI.</description><identifier>ISSN: 3005-074X</identifier><identifier>EISSN: 3005-074X</identifier><identifier>DOI: 10.1186/s41824-024-00225-5</identifier><language>eng</language><ispartof>EJNMMI reports, 2024-11, Vol.8 (1), p.37</ispartof><rights>2024. The Author(s).</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Glemser, Philip Alexander</creatorcontrib><creatorcontrib>Freitag, Martin</creatorcontrib><creatorcontrib>Kovacs, Balint</creatorcontrib><creatorcontrib>Netzer, Nils</creatorcontrib><creatorcontrib>Dimitrakopoulou-Strauss, Antonia</creatorcontrib><creatorcontrib>Haberkorn, Uwe</creatorcontrib><creatorcontrib>Maier-Hein, Klaus</creatorcontrib><creatorcontrib>Schwab, Constantin</creatorcontrib><creatorcontrib>Duensing, Stefan</creatorcontrib><creatorcontrib>Beuthien-Baumann, Bettina</creatorcontrib><creatorcontrib>Schlemmer, Heinz-Peter</creatorcontrib><creatorcontrib>Bonekamp, David</creatorcontrib><creatorcontrib>Giesel, Frederik</creatorcontrib><creatorcontrib>Sachpekidis, Christos</creatorcontrib><title>Enhancing the diagnostic capacity of 18FPSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study</title><title>EJNMMI reports</title><description>To investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [18F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in patients with primary prostate cancer (PC).BACKGROUNDTo investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [18F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in patients with primary prostate cancer (PC).A total of seven patients underwent whole-body [18F]-PSMA-1007 PET/MRI examinations including a pelvic mpMRI protocol with T2w, diffusion weighted imaging (DWI) and DCE image series. Conventional analysis included visual reading of PET/MRI images and Prostate Imaging Reporting & Data System (PI-RADS) scoring of the prostate. On the prostate level, we performed manual segmentations for time-intensity curve parameter formation and semi-quantitative analysis based on DCE segmentation data of PC-suspicious lesions. Moreover, we applied a recently introduced deep learning (DL) pipeline previously trained on 1010 independent MRI examinations with systematic biopsy-enhanced histopathological targeted biopsy lesion ground truth in order to perform AI-based lesion detection, prostate segmentation and derivation of a deep learning PI-RADS score. DICE coefficients between manual and automatic DL-acquired segmentations were compared. On patient-based analysis, PET/MRI revealed PC-suspicious lesions in the prostate gland in 6/7 patients (Gleason Score-GS ≥ 7b) that were histologically confirmed. Four of these patients also showed lymph node metastases, while two of them had bone metastases. One patient with GS 6 showed no PC-suspicious lesions. Based on DCE segmentations, a distinction between PC-suspicious and normal appearing tissue was feasible with the parameters fitted maximum contrast ratio (FMCR) and wash-in-slope. DICE coefficients (manual vs. deep learning) were comparable with literature values at a mean of 0.44. Further, the DL pipeline could identify the intraprostatic PC-suspicious lesions in all six patients with clinically significant PC.RESULTSA total of seven patients underwent whole-body [18F]-PSMA-1007 PET/MRI examinations including a pelvic mpMRI protocol with T2w, diffusion weighted imaging (DWI) and DCE image series. Conventional analysis included visual reading of PET/MRI images and Prostate Imaging Reporting & Data System (PI-RADS) scoring of the prostate. On the prostate level, we performed manual segmentations for time-intensity curve parameter formation and semi-quantitative analysis based on DCE segmentation data of PC-suspicious lesions. Moreover, we applied a recently introduced deep learning (DL) pipeline previously trained on 1010 independent MRI examinations with systematic biopsy-enhanced histopathological targeted biopsy lesion ground truth in order to perform AI-based lesion detection, prostate segmentation and derivation of a deep learning PI-RADS score. DICE coefficients between manual and automatic DL-acquired segmentations were compared. On patient-based analysis, PET/MRI revealed PC-suspicious lesions in the prostate gland in 6/7 patients (Gleason Score-GS ≥ 7b) that were histologically confirmed. Four of these patients also showed lymph node metastases, while two of them had bone metastases. One patient with GS 6 showed no PC-suspicious lesions. Based on DCE segmentations, a distinction between PC-suspicious and normal appearing tissue was feasible with the parameters fitted maximum contrast ratio (FMCR) and wash-in-slope. DICE coefficients (manual vs. deep learning) were comparable with literature values at a mean of 0.44. Further, the DL pipeline could identify the intraprostatic PC-suspicious lesions in all six patients with clinically significant PC.Firstly, semi-quantitative DCE analysis based on manual segmentations of time-intensity curves was able to distinguish benign from malignant tissues. Moreover, DL analysis of the MRI data could detect clinically significant PC in all cases, demonstrating the feasibility of AI-supported approaches in increasing diagnostic certainty of PSMA-radioligand PET/MRI.CONCLUSIONFirstly, semi-quantitative DCE analysis based on manual segmentations of time-intensity curves was able to distinguish benign from malignant tissues. Moreover, DL analysis of the MRI data could detect clinically significant PC in all cases, demonstrating the feasibility of AI-supported approaches in increasing diagnostic certainty of PSMA-radioligand PET/MRI.</description><issn>3005-074X</issn><issn>3005-074X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqVjTFPwzAQhS0EEhX0DzDdyBJ6jpMmsKGSqgyVKujAVp1cJzmUOGnsAP1J_EtciYGV4fTu6d73TogbiXdS5vOZS2QeJxGeBuM4jdIzMVGIaYRZ8nb-Z78UU-feEVEpzGI1n4jvwtZkNdsKfG1gz1TZznnWoKknzf4IXQkyX25e14-RRMxgU2xn65dnYAv9wC0Nx6CBIW8CZLUZIJjqVPnJvgYaPJesmZqAeNM0XJmQArJ7cKbl6DCS9Rx4_jDwtCgewgnMV990A_ku1Ds_7o_X4qKkxpnpr16J22WxXayi8PwwGud3LTsd6smabnQ7JeNcxZjfJ-of0R81-Wno</recordid><startdate>20241108</startdate><enddate>20241108</enddate><creator>Glemser, Philip Alexander</creator><creator>Freitag, Martin</creator><creator>Kovacs, Balint</creator><creator>Netzer, Nils</creator><creator>Dimitrakopoulou-Strauss, Antonia</creator><creator>Haberkorn, Uwe</creator><creator>Maier-Hein, Klaus</creator><creator>Schwab, Constantin</creator><creator>Duensing, Stefan</creator><creator>Beuthien-Baumann, Bettina</creator><creator>Schlemmer, Heinz-Peter</creator><creator>Bonekamp, David</creator><creator>Giesel, Frederik</creator><creator>Sachpekidis, Christos</creator><scope>7X8</scope></search><sort><creationdate>20241108</creationdate><title>Enhancing the diagnostic capacity of 18FPSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study</title><author>Glemser, Philip Alexander ; Freitag, Martin ; Kovacs, Balint ; Netzer, Nils ; Dimitrakopoulou-Strauss, Antonia ; Haberkorn, Uwe ; Maier-Hein, Klaus ; Schwab, Constantin ; Duensing, Stefan ; Beuthien-Baumann, Bettina ; Schlemmer, Heinz-Peter ; Bonekamp, David ; Giesel, Frederik ; Sachpekidis, Christos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_31283208943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glemser, Philip Alexander</creatorcontrib><creatorcontrib>Freitag, Martin</creatorcontrib><creatorcontrib>Kovacs, Balint</creatorcontrib><creatorcontrib>Netzer, Nils</creatorcontrib><creatorcontrib>Dimitrakopoulou-Strauss, Antonia</creatorcontrib><creatorcontrib>Haberkorn, Uwe</creatorcontrib><creatorcontrib>Maier-Hein, Klaus</creatorcontrib><creatorcontrib>Schwab, Constantin</creatorcontrib><creatorcontrib>Duensing, Stefan</creatorcontrib><creatorcontrib>Beuthien-Baumann, Bettina</creatorcontrib><creatorcontrib>Schlemmer, Heinz-Peter</creatorcontrib><creatorcontrib>Bonekamp, David</creatorcontrib><creatorcontrib>Giesel, Frederik</creatorcontrib><creatorcontrib>Sachpekidis, Christos</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>EJNMMI reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glemser, Philip Alexander</au><au>Freitag, Martin</au><au>Kovacs, Balint</au><au>Netzer, Nils</au><au>Dimitrakopoulou-Strauss, Antonia</au><au>Haberkorn, Uwe</au><au>Maier-Hein, Klaus</au><au>Schwab, Constantin</au><au>Duensing, Stefan</au><au>Beuthien-Baumann, Bettina</au><au>Schlemmer, Heinz-Peter</au><au>Bonekamp, David</au><au>Giesel, Frederik</au><au>Sachpekidis, Christos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhancing the diagnostic capacity of 18FPSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study</atitle><jtitle>EJNMMI reports</jtitle><date>2024-11-08</date><risdate>2024</risdate><volume>8</volume><issue>1</issue><spage>37</spage><pages>37-</pages><issn>3005-074X</issn><eissn>3005-074X</eissn><abstract>To investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [18F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in patients with primary prostate cancer (PC).BACKGROUNDTo investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [18F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in patients with primary prostate cancer (PC).A total of seven patients underwent whole-body [18F]-PSMA-1007 PET/MRI examinations including a pelvic mpMRI protocol with T2w, diffusion weighted imaging (DWI) and DCE image series. Conventional analysis included visual reading of PET/MRI images and Prostate Imaging Reporting & Data System (PI-RADS) scoring of the prostate. On the prostate level, we performed manual segmentations for time-intensity curve parameter formation and semi-quantitative analysis based on DCE segmentation data of PC-suspicious lesions. Moreover, we applied a recently introduced deep learning (DL) pipeline previously trained on 1010 independent MRI examinations with systematic biopsy-enhanced histopathological targeted biopsy lesion ground truth in order to perform AI-based lesion detection, prostate segmentation and derivation of a deep learning PI-RADS score. DICE coefficients between manual and automatic DL-acquired segmentations were compared. On patient-based analysis, PET/MRI revealed PC-suspicious lesions in the prostate gland in 6/7 patients (Gleason Score-GS ≥ 7b) that were histologically confirmed. Four of these patients also showed lymph node metastases, while two of them had bone metastases. One patient with GS 6 showed no PC-suspicious lesions. Based on DCE segmentations, a distinction between PC-suspicious and normal appearing tissue was feasible with the parameters fitted maximum contrast ratio (FMCR) and wash-in-slope. DICE coefficients (manual vs. deep learning) were comparable with literature values at a mean of 0.44. Further, the DL pipeline could identify the intraprostatic PC-suspicious lesions in all six patients with clinically significant PC.RESULTSA total of seven patients underwent whole-body [18F]-PSMA-1007 PET/MRI examinations including a pelvic mpMRI protocol with T2w, diffusion weighted imaging (DWI) and DCE image series. Conventional analysis included visual reading of PET/MRI images and Prostate Imaging Reporting & Data System (PI-RADS) scoring of the prostate. On the prostate level, we performed manual segmentations for time-intensity curve parameter formation and semi-quantitative analysis based on DCE segmentation data of PC-suspicious lesions. Moreover, we applied a recently introduced deep learning (DL) pipeline previously trained on 1010 independent MRI examinations with systematic biopsy-enhanced histopathological targeted biopsy lesion ground truth in order to perform AI-based lesion detection, prostate segmentation and derivation of a deep learning PI-RADS score. DICE coefficients between manual and automatic DL-acquired segmentations were compared. On patient-based analysis, PET/MRI revealed PC-suspicious lesions in the prostate gland in 6/7 patients (Gleason Score-GS ≥ 7b) that were histologically confirmed. Four of these patients also showed lymph node metastases, while two of them had bone metastases. One patient with GS 6 showed no PC-suspicious lesions. Based on DCE segmentations, a distinction between PC-suspicious and normal appearing tissue was feasible with the parameters fitted maximum contrast ratio (FMCR) and wash-in-slope. DICE coefficients (manual vs. deep learning) were comparable with literature values at a mean of 0.44. Further, the DL pipeline could identify the intraprostatic PC-suspicious lesions in all six patients with clinically significant PC.Firstly, semi-quantitative DCE analysis based on manual segmentations of time-intensity curves was able to distinguish benign from malignant tissues. Moreover, DL analysis of the MRI data could detect clinically significant PC in all cases, demonstrating the feasibility of AI-supported approaches in increasing diagnostic certainty of PSMA-radioligand PET/MRI.CONCLUSIONFirstly, semi-quantitative DCE analysis based on manual segmentations of time-intensity curves was able to distinguish benign from malignant tissues. Moreover, DL analysis of the MRI data could detect clinically significant PC in all cases, demonstrating the feasibility of AI-supported approaches in increasing diagnostic certainty of PSMA-radioligand PET/MRI.</abstract><doi>10.1186/s41824-024-00225-5</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 3005-074X |
ispartof | EJNMMI reports, 2024-11, Vol.8 (1), p.37 |
issn | 3005-074X 3005-074X |
language | eng |
recordid | cdi_proquest_miscellaneous_3128320894 |
source | Springer Nature - SpringerLink Journals - Fully Open Access ; PubMed Central |
title | Enhancing the diagnostic capacity of 18FPSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A52%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhancing%20the%20diagnostic%20capacity%20of%2018FPSMA-1007%20PET/MRI%20in%20primary%20prostate%20cancer%20staging%20with%20artificial%20intelligence%20and%20semi-quantitative%20DCE:%20an%20exploratory%20study&rft.jtitle=EJNMMI%20reports&rft.au=Glemser,%20Philip%20Alexander&rft.date=2024-11-08&rft.volume=8&rft.issue=1&rft.spage=37&rft.pages=37-&rft.issn=3005-074X&rft.eissn=3005-074X&rft_id=info:doi/10.1186/s41824-024-00225-5&rft_dat=%3Cproquest%3E3128320894%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_31283208943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3128320894&rft_id=info:pmid/&rfr_iscdi=true |